QIAGEN achieves Personalized Healthcare milestone with U.S. approval of companion diagnostic for colorectal cancer
. - U.S. launch of therascreen® KRAS RGQ PCR Kit offers enhanced approach to guide treatments for approximately 110,000…
. - U.S. launch of therascreen® KRAS RGQ PCR Kit offers enhanced approach to guide treatments for approximately 110,000…
. - Diagnostic workflow for C. difficile is launched in Europe and submitted in the U.S. for 510(k) clearance as the fi…
. - U.S. submission of therascreen® EGFR RGQ PCR Kit is paired with FDA submission of afatinib, an investigational tyro…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
A fast, flexible, and reliable isolation of pure nucleic acids from various sample materials is crucial for sensitive mo…
QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has entered into an agreement with the Ins…
In order to enhance the worldwide launch of its innovative food safety testing systems, BIOTECON Diagnostics has formed…
Q2 2013 results: Adjusted net sales of $316.4 million (+3% CER) on growth in all regions; adjusted operating income of $…
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promo…
Roche Diagnostics and Exiqon A/S, Vedbæk, Denmark, a provider of high-value gene expression analysis products, today ann…